Short answer · Medically reviewed summary · Last updated: 2026-04-08
McCune-Albright syndrome is a rare genetic condition characterized by the triad of fibrous dysplasia of bone, café-au-lait skin pigmentation, and hyperfunctioning endocrine disorders. While it is most commonly referred to by its eponymous name, it is sometimes historically or clinically identified as Albright syndrome or polyostotic fibrous dysplasia with endocrine dysfunction. What are the primary synonyms and names for McCune-Albright syndrome? In medical literature, McCune-Albright syndrome is the universally accepted term.
McCune-Albright syndrome is a rare genetic condition characterized by the triad of fibrous dysplasia of bone, café-au-lait skin pigmentation, and hyperfunctioning endocrine disorders. While it is most commonly referred to by its eponymous name, it is sometimes historically or clinically identified as Albright syndrome or polyostotic fibrous dysplasia with endocrine dysfunction.
In medical literature, McCune-Albright syndrome is the universally accepted term. However, patients may encounter various synonyms depending on the era of the publication or the specific clinical focus of the medical report. Historically, the condition was described using terms that highlighted its most prominent physical manifestations. Common synonyms and historical names include Albright syndrome, polyostotic fibrous dysplasia, and, in older texts, osteitis fibrosa disseminata. Because McCune-Albright syndrome affects multiple systems, clinicians sometimes refer to the specific endocrine components, such as gonadotropin-independent precocious puberty, but these are clinical features rather than official disease names.
The naming of McCune-Albright syndrome reflects the history of medical discovery. The condition was independently described by Donovan McCune and Fuller Albright in 1937. Over time, as our understanding of the underlying GNAS gene mutation evolved, the medical community moved toward a consolidated name to avoid confusion. Using multiple names in the past often occurred because different specialists—such as endocrinologists, orthopedists, and dermatologists—would name the condition based on the specific symptom they were treating. Today, McCune-Albright syndrome is the preferred nomenclature in all major medical databases to ensure consistency in research and patient care.
Standardizing the name is vital for patient diagnosis and access to care. Major health organizations use specific codes to categorize McCune-Albright syndrome for billing, research, and international monitoring:
For the 62 members of the McCune-Albright syndrome community on DiseaseMaps.org and patients worldwide, using the official name is essential for navigating medical records and research. When searching for clinical trials or peer-reviewed literature, using the term McCune-Albright syndrome ensures that you access the most current data regarding the GNAS somatic mutation. Relying on older, synonymous terms can lead to outdated information or fragmented searches, potentially obscuring recent advancements in treatment options or management strategies.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.